Clinical and molecular significance of the RNA m(6)A methyltransferase complex in prostate cancer.
Lothion-Roy J, Haigh DB, Harris AE, Metzler VM, Alsaleem M, Toss MS, Kariri Y, Ntekim A, Robinson BD, Khani F, Gudas LJ, Allegrucci C, James VH, Madhusudan S, Mather M, Emes RD, Archer N, Fray RG, Rakha E, Jeyapalan JN, Rutland CS, Mongan NP, Woodcock CL.
Lothion-Roy J, et al.
Front Genet. 2023 Jan 12;13:1096071. doi: 10.3389/fgene.2022.1096071. eCollection 2022.
Front Genet. 2023.
PMID: 36733939
Free PMC article.
N(6)-methyladenosine (m(6)A) is the most abundant internal mRNA modification and is dynamically regulated through distinct protein complexes that methylate, demethylate, and/or interpret the m(6)A modification. These proteins, and the m(6)A modification, are …
N(6)-methyladenosine (m(6)A) is the most abundant internal mRNA modification and is dynamically regulated through distinct protein co …